Basic Information
Cantai Therapeutics is advancing drugs for the treatment of autoimmune and inflammatory diseases by developing cytokines that target bispecific antibodies. The agent conceived this idea for Cantai's products and collaborated with 82VS to further develop the concept.
Cantai Therapeutics
Massachusetts,United States of America
unclear
--
--
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios